With the rapid development of precision medicine, targeted drugs have become a key approach in cancer treatment. Unlike traditional chemotherapy, targeted therapy “hits” specific...

WHO Releases First GLP-1 Obesity Treatment Guideline, Signaling New Opportunities for the Global Pharma IndustryThe World Health Organization (WHO) has issued its first global guid...

When discussing overseas generic drugs, “Indian generics” and “Bangladeshi generics” are often mentioned together. Although both are widely used and cost-effective, they differ...

Many people have heard that a generic drug is considered reliable only if it has passed “BE certification.” But what does BE actually mean? And why is it so important for generic...

Natural killer (NK) cells play a central role within the innate immune system and are able to recognize abnormal cells without prior sensitization. In recent years, NK cell–based ...

This page summarizes the latest approvals issued by the U.S. Food and Drug Administration (FDA). The list includes newly approved therapies as well as additional indications for ex...

The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...

The U.S. Food and Drug Administration (FDA) has officially approved Novartis’ latest gene replacement therapy, Itvisma, marking a significant milestone in the treatment landscape ...

Obesity has become a major global public health challenge. According to the World Obesity Federation, approximately 3 billion people worldwide were overweight or obese by 2024. Exc...

Breast cancer remains the most commonly diagnosed cancer among women worldwide. Although its发病 trends and risk factors have been extensively studied, public understanding of how ...